←Back to Expert Scholars
Translational Medicine / 转化医学Pediatric HCT, Late Effects
Rachel Phelan
MD, MPH
🏢Medical College of Wisconsin🌐USA
Associate Professor of Pediatrics
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Rachel Phelan leads CIBMTR pediatric outcomes research focusing on late effects and long-term survivorship after childhood HCT. Her studies inform survivorship care guidelines and risk-adapted follow-up. She collaborates widely with pediatric transplant consortia.
Share:
🧪Research Fields 研究领域
CIBMTR
pediatric HCT
late effects
survivorship
registry research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Rachel Phelan 的研究动态
Follow Rachel Phelan's research updates
留下邮箱，当我们发布与 Rachel Phelan（Medical College of Wisconsin）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment